a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders
Industry Biotechnology
A.I.dvisor indicates that over the last year, HRMY has been loosely correlated with GYRE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if HRMY jumps, then GYRE could also see price increases.
Ticker / NAME | Correlation To HRMY | 1D Price Change % | ||
---|---|---|---|---|
HRMY | 100% | +1.03% | ||
GYRE - HRMY | 36% Loosely correlated | -11.26% | ||
SNDX - HRMY | 35% Loosely correlated | -0.05% | ||
PRTA - HRMY | 34% Loosely correlated | -4.63% | ||
IDYA - HRMY | 33% Poorly correlated | -3.52% | ||
AXSM - HRMY | 31% Poorly correlated | +0.89% | ||
More |
Ticker / NAME | Correlation To HRMY | 1D Price Change % |
---|---|---|
HRMY | 100% | +1.03% |
therapies theme (2 stocks) | 99% Closely correlated | +0.07% |
brain theme (2 stocks) | 98% Closely correlated | -0.63% |
pharmaceutical theme (4 stocks) | 67% Closely correlated | -0.20% |
treatment theme (61 stocks) | 29% Poorly correlated | +0.91% |